Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Rehkämper

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Hematology|April 28, 2018
DNA damage pathways and B-cell lymphomagenesisGero Knittel, Tim Rehkämper, Pascal Nieper, et al.
Scientific Reports|November 16, 2017
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancerFabian Doerr, Julie George, Anna Schmitt, et al.
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Hematology|April 28, 2018
DNA damage pathways and B-cell lymphomagenesisGero Knittel, Tim Rehkämper, Pascal Nieper, et al.
Scientific Reports|November 16, 2017
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancerFabian Doerr, Julie George, Anna Schmitt, et al.
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 1